July 18, 2014

FedEx on Thursday was indicted as a co-conspirator for illegally distributing pharmaceuticals sourced from a pair of rogue online pharmacies.

 

July 10, 2014

As lifetime earnings for pharmaceuticals decrease, commercialization expenses increase and payers tighten their belts on reimbursement, life science companies will be faced with shrinking margins over the next few years. In order to maintain basic operating margin levels and continue investing in research and development at current levels, life science manufacturers will be forced to reduce costs by more than $35 billion by 2017, according to results from a new survey of 70 life science organizations from the IMS Institute for Healthcare Informatics.

May 13, 2014

KVK-Tech, a developer, manufacturer and marketer of specialty pharmaceuticals, announced the appointment of Joseph Lefebvre as VP business development, marketing and API sourcing.

May 9, 2014

A panel of speakers from all facets of health care convened yesterday to discuss the growth of the specialty pharmaceuticals industry during the 10th Annual Specialty Pharmacy Summit & Expo, hosted by Armada Health Care.

April 29, 2014

Endo International on Tuesday announced that it will acquire Somar, a privately-owned specialty pharmaceuticals company based in Mexico City, Mexico.

April 29, 2014

Jubilant Life Sciences, an integrated pharmaceuticals and life sciences company, last week announced that it received approval from the Food and Drug Administration for spironolactone tablets, 25 mg, 50 mg and 100 mg, which is the generic version of Aldactone.

April 28, 2014

As lifetime earnings for pharmaceuticals decrease, commercialization expenses increase and payers tighten their belts on reimbursement, life science companies will be faced with shrinking margins over the next few years.

April 28, 2014

McKesson Specialty Health, a division of McKesson Corp., last week announced the integration of its distribution services with General Medical Services' Physician Office Drug Inventory System.

April 7, 2014

Mallinckrodt and Questcor Pharmaceuticals on Monday announced that they have entered into a definitive merger agreement under which Mallinckrodt will acquire Questcor in a transaction valued at approximately $5.6 billion.

April 2, 2014

Symphony Health Solutions on Wednesday released research on the affects of the Affordable Care Act on Medicaid drug spending.

March 28, 2014

Lupin on Thursday announced the acquisition of 100% equity stake in Laboratorios Grin, subject to certain closing conditions.

March 24, 2014

AmerisourceBergen on Monday announced that it has reached a definitive agreement to acquire a minority stake in Profarma Distribuidora de Produtos Farmacêuticos S.A., a leading pharmaceutical wholesaler in Brazil.

March 20, 2014

Johnson & Johnson on Wednesday named Ernesto Quinteros, recently of Belkin International, as its chief design officer.

March 20, 2014

Mallinckrodt, a specialty pharmaceuticals company, announced the completion of its acquisition of Cadence Pharmaceuticals for approximately $1.4 billion.

March 13, 2014

More Americans are more often seeking their ounce of prevention. According to Bain & Co.’s recent Healthy Living Survey, 75% of consumers are in pursuit of a healthier lifestyle. Take that predominant mindset, coupled with the outcomes-driven preventive focus associated with the Affordable Care Act, and you have a formula for OTC success at retail pharmacy.

March 10, 2014

Although the United States is still waiting for final practical guidelines from the Food and Drug Administration about the launch of biosimilars and the standards required to meet the threshold of interchangeability, the rest of the world seems to be barreling forward with the development and launch of these important medicines.

March 7, 2014

Wegmans has expanded its pharmaceutical services to include the family pet, according a recent blog.

February 18, 2014

Actavis and Forest Labs. announced that they have entered into a definitive agreement under which Actavis will acquire Forest for a combination of cash and equity valued at approximately $25 billion, or $89.48 per Forest share ($26.04 in cash and 0.3306 Actavis shares for each share of Forest common stock).

February 18, 2014

McKesson and Rite Aid on Tuesday announced the signing of an expanded distribution agreement to include both brand and generic pharmaceuticals.

February 3, 2014

The Generic Pharmaceutical Association on Monday identified its key priorities for 2014 — guarding against confusion a proposed labeling change would cause; gaining access to biosimilar generics; and heralding the cost savings generated by generic utilization.

January 24, 2014

Hi-Tech Pharmacal Co., a specialty pharmaceuticals company, announced that it was granted final approval from the Food and Drug Administration for bromfenac ophthalmic solution 0.09% (once-a-day).

January 14, 2014

H.D. Smith celebrates 60 years of business in 2014, the wholesaler announced Monday.

January 9, 2014

A confluence of healthcare trends has expanded a lucrative, if challenging, opportunity for pharmacies able to invest in its potential.

December 17, 2013

Forty blockbuster drugs will use patent exclusivity in the United States between this year and 2020, according to a new study.